Welcome to Cardiac Safety 2006, Central London, UK
(Date TBC)
Cardiac Safety is a central topic of debate following recent ICH E14 and S7b guidelines and new concerns regarding drug development. At a time when Biotech and Pharmaceutical companies are facing increasing pressure to meet stricter cardiac safety requirements in a timely and economic manner, this conference explores the fundamental principles of cardiac safety and presents practical experience delivered in thought-provoking presentations from giant manufacturers and leading academics working in this difficult field.
This event will explore important trends in drug development, consider different approaches to QT assessment, discuss preclinical predictivity and sudden cardiac death. The 6th Annual Cardiac Safety conference analyses the approach that manufacturing companies have taken across Europe and the USA. This conference comprehensively covers the key problems you are facing today.
